Bahig, H., Yuan, Y., Mohamed, A. S., Brock, K. K., Ng, S. P., Wang, J., Ding, Y., Hutcheson, K., McCulloch, M., Balter, P. A., Lai, S. Y., Al-Mamgani, A., Sonke, J., van der Heide, U. A., Nutting, C., Li, X. A., Robbins, J., Awan, M., Karam, I., Newbold, K., Harrington, K., Oelfke, U., Bhide, S., Philippens, M. E., Terhaard, C. H., McPartlin, A. J., Blanchard, P., Garden, A. S., Rosenthal, D. I., Gunn, G. B., Phan, J., Cazoulat, G., Aristophanous, M., McSpadden, K. K., Garcia, J. A., van den Berg, C. A., Raaijmakers, C. P., Kerkmeijer, L., Doornaert, P., Blinde, S., Frank, S. J., & Fuller, C. D. (2018). magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial. Clinical and translational radiation oncology, 13, 19–23. http://access.bl.uk/ark:/81055/vdc_100070802798.0x000004